Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new shampoo outsmart dandruff in Hijab-Wearing women?

NCT ID NCT07802808

Disease control Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests whether a shampoo with piroctone olamine can ease seborrheic dermatitis, a common cause of dandruff, in hijab-wearing women. Researchers compare it to a standard ketoconazole shampoo to see which better improves scalp symptoms and skin health. Participants use the assigned shampoo and provide scalp samples to check for changes in microbes and skin moisture. The study aims to offer a safe, effective option for women who cover their hair.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Piroctone olamine 0.75% shampoo, compared against ketoconazole 2% shampoo
What this could lead to
If it works, this could offer hijab-wearing women with seborrheic dermatitis a gentler or equally effective alternative to ketoconazole shampoo, with fewer side effects.
What could go wrong
This is a small, early-stage comparison. The shampoo may not work as well as ketoconazole, and results may not apply to all women or other forms of dandruff.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

86 people

The number who actually took part.

Started

Jan 2026

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hijab-wearing women with mild, moderate, or severe seborrheic dermatitis. * Aged 18 to 59 years. * Willing to participate in the study and able to provide written informed consent Exclusion Criteria: * Diagnosis of another hair or scalp condition, such as alopecia, trichotillomania, malignancy, or scalp infection, based on medical history. * Current use of medication or treatment for the hair or scalp. * Current use of cytostatic therapy for malignancy or other cytostatic medications. * Known hypersensitivity to the shampoo base or any of its ingredients, based on medical history. * Pregnancy or breastfeeding. * Current use of additional hair or scalp-care products. * History of liver disease, kidney disease, vitiligo, or psoriasis, based on medical history.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Seborrheic dermatitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

seborrheic dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Seborrheic dermatitis

Contacts and locations

Locations

  • dr. Cipto Mangunkusumo General Hospital

    Jakarta, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.